FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003404238> ?p ?o ?g. }

• W2003404238 endingPage "130" @default.
• W2003404238 startingPage "125" @default.
• W2003404238 abstract "Purpose: To develop a new technique, intraoperative high dose rate brachytherapy (IOHDR), to deliver localized radiation therapy intraoperatively to head and neck tumors at sites inaccessible to intraoperative electron beam radiotherapy (IOEBRT) in the skull base region. Methods: After maximal surgical resection, afterloading catheters spaced 1 cm apart embedded in custom surface applicators made of foam or silicone were placed on resected tumor beds. IOHDR was delivered in a shielded operating room using preplanned dosimetry with a nominal 10 Ci iridium-192 source in an HDR micro-Selectron afterloader. Twenty-nine patients (20 males, 9 females) ranging in age from 9 to 80 years (median = 61) were irradiated intraoperatively for advanced head and neck tumors at sites inaccessible to IOEBRT. Six patients who had previously received external beam radiation (EBRT) ranging from 50 to 75 Gy, were given 15 Gy of IOHDR only. Twenty-three patients who had no prior radiation received 7.5 to 12.5 Gy IOHDR, and 45 to 50 Gy EBRT was planned post-operatively; however, six of these patients did not complete the planned EBRT. Doses to normal tissues were reduced whenever possible by shielding with lead or by displacement with gauze or retractors. Treatment time ranged from 3.8 to 23 min (median = 6.5 min). Five patients received concurrent cis-platinum based chemotherapy. Results: Twenty-nine patients treated to 30 sites had local tumor control of 67% and crude survival of 72%, with the follow-up ranging from 3 to 33 months (median = 21 months). In the group of 17 previously unirradiated patients who had completed full treatment (IOHDR and EBRT) to 18 sites, the local tumor control was 89%, and all of these patients survived. Tumor control in the six previously unirradiated patients who did not complete EBRT was 50% with a crude survival of 50%. In the group of six previously irradiated patients treated by IOHDR only, the local tumor control was 17% with a crude survival of 17%. No intraoperative complications were noted. The delayed morbidity included cerebrospinal fluid (CSF) leak with bone exposure (1), chronic subdural hematoma (1), septicemia (1), otitis media (1), and severe xerostomia (1). We cannot comment on long-term morbidity due to the relatively short follow-up period of 21 months. Conclusions: It is feasible to deliver IOHDR, with acceptable toxicity, to skull base tumors at sites inaccessible to IOEBRT. The use of IOHDR as a pre-radiotherapy boost produced excellent local control and survival in the selected group of patients who had no previous radiation therapy. The use of exclusive IOHDR in the previously irradiated group resulted in poor outcome, possibly due to the limitations on re-irradiation doses and/or volumes determined by normal tissue tolerance or because these patients have inherently radioresistant tumors. Higher IOHDR doses, additional EBRT, and/or chemotherapy should be considered for this group. The use of IOHDR as a pre-EBRT boost to maximize local control has a promising future in the treatment of carefully selected patients with advanced skull base tumor." @default.
• W2003404238 created "2016-06-24" @default.
• W2003404238 creator A5006222899 @default.
• W2003404238 creator A5012134619 @default.
• W2003404238 creator A5023083148 @default.
• W2003404238 creator A5026579804 @default.
• W2003404238 creator A5030567701 @default.
• W2003404238 creator A5042549893 @default.
• W2003404238 creator A5055245295 @default.
• W2003404238 date "1996-11-01" @default.
• W2003404238 modified "2023-10-15" @default.
• W2003404238 title "Pilot study of intraoperative high dose rate brachytherapy for head and neck cancer" @default.
• W2003404238 cites W1967353808 @default.
• W2003404238 cites W1973707580 @default.
• W2003404238 cites W1978826908 @default.
• W2003404238 cites W1993956122 @default.
• W2003404238 cites W1997709998 @default.
• W2003404238 cites W2000520890 @default.
• W2003404238 cites W2017412388 @default.
• W2003404238 cites W2022775755 @default.
• W2003404238 cites W2044320683 @default.
• W2003404238 cites W2058421735 @default.
• W2003404238 cites W2058670362 @default.
• W2003404238 cites W2094404117 @default.
• W2003404238 cites W2128307218 @default.
• W2003404238 doi "https://doi.org/10.1016/s0167-8140(96)01823-3" @default.
• W2003404238 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9004354" @default.
• W2003404238 hasPublicationYear "1996" @default.
• W2003404238 type Work @default.
• W2003404238 sameAs 2003404238 @default.
• W2003404238 citedByCount "33" @default.
• W2003404238 countsByYear W20034042382013 @default.
• W2003404238 countsByYear W20034042382014 @default.
• W2003404238 countsByYear W20034042382016 @default.
• W2003404238 countsByYear W20034042382017 @default.
• W2003404238 countsByYear W20034042382018 @default.
• W2003404238 countsByYear W20034042382021 @default.
• W2003404238 countsByYear W20034042382022 @default.
• W2003404238 crossrefType "journal-article" @default.
• W2003404238 hasAuthorship W2003404238A5006222899 @default.
• W2003404238 hasAuthorship W2003404238A5012134619 @default.
• W2003404238 hasAuthorship W2003404238A5023083148 @default.
• W2003404238 hasAuthorship W2003404238A5026579804 @default.
• W2003404238 hasAuthorship W2003404238A5030567701 @default.
• W2003404238 hasAuthorship W2003404238A5042549893 @default.
• W2003404238 hasAuthorship W2003404238A5055245295 @default.
• W2003404238 hasConcept C126838900 @default.
• W2003404238 hasConcept C141071460 @default.
• W2003404238 hasConcept C2776530083 @default.
• W2003404238 hasConcept C2777416452 @default.
• W2003404238 hasConcept C2779494622 @default.
• W2003404238 hasConcept C2989005 @default.
• W2003404238 hasConcept C3018411727 @default.
• W2003404238 hasConcept C509974204 @default.
• W2003404238 hasConcept C71924100 @default.
• W2003404238 hasConceptScore W2003404238C126838900 @default.
• W2003404238 hasConceptScore W2003404238C141071460 @default.
• W2003404238 hasConceptScore W2003404238C2776530083 @default.
• W2003404238 hasConceptScore W2003404238C2777416452 @default.
• W2003404238 hasConceptScore W2003404238C2779494622 @default.
• W2003404238 hasConceptScore W2003404238C2989005 @default.
• W2003404238 hasConceptScore W2003404238C3018411727 @default.
• W2003404238 hasConceptScore W2003404238C509974204 @default.
• W2003404238 hasConceptScore W2003404238C71924100 @default.
• W2003404238 hasIssue "2" @default.
• W2003404238 hasLocation W20034042381 @default.
• W2003404238 hasLocation W20034042382 @default.
• W2003404238 hasOpenAccess W2003404238 @default.
• W2003404238 hasPrimaryLocation W20034042381 @default.
• W2003404238 hasRelatedWork W2090872048 @default.
• W2003404238 hasRelatedWork W2147863910 @default.
• W2003404238 hasRelatedWork W2182466796 @default.
• W2003404238 hasRelatedWork W2291038930 @default.
• W2003404238 hasRelatedWork W2389281101 @default.
• W2003404238 hasRelatedWork W2411709837 @default.
• W2003404238 hasRelatedWork W2949811493 @default.
• W2003404238 hasRelatedWork W3107042173 @default.
• W2003404238 hasRelatedWork W3138304378 @default.
• W2003404238 hasRelatedWork W4240628612 @default.
• W2003404238 hasVolume "41" @default.
• W2003404238 isParatext "false" @default.
• W2003404238 isRetracted "false" @default.
• W2003404238 magId "2003404238" @default.
• W2003404238 workType "article" @default.